C27H25F2N3O5
Neat
509.51
1206102-11-5; (4R, 12aS)-7-(Benzyloxy)-N-(2, 4-difluorobenzyl)-4-methyl-6, 8-dioxo-3, 4, 6, 8, 12, 12a-hexahydro-2H-pyrido[1', 2':4, 5]pyrazino[2, 1-b][1, 3]oxazine-9-carboxamide; Dolutegravir o-benzyl impurity; SJ4GZ8739L; (4R, 12aS)-7-(Benzyloxy)-N-(2, 4-difluorobenzyl)-4-methyl-6, 8-dioxo-3, 4, 6, 8, 12, 12a-hexahydro-2H-pyrido(1', 2':4, 5)pyrazino(2, 1-b)(1, 3)oxazine-9-carboxamide; (4R, 12aS)-N-((2, 4-Difluorophenyl)methyl)-3, 4, 6, 8, 12, 12a-hexahydro-4-methyl-6, 8-dioxo-7-(phenylmethoxy)-2H-pyrido(1', 2':4, 5)pyrazino(2, 1-b)(1, 3)oxazine-9-carboxamide; 2H-Pyrido(1', 2':4, 5)pyrazino(2, 1-b)(1, 3)oxazine-9-carboxamide, N-((2, 4-difluorophenyl)methyl)-3, 4, 6, 8, 12, 12a-hexahydro-4-methyl-6, 8-dioxo-7-(phenylmethoxy)-, (4R, 12aS)-; 2H-Pyrido[1', 2':4, 5]pyrazino[2, 1-b][1, 3]oxazine-9-carboxamide, N-[(2, 4-difluorophenyl)methyl]-3, 4, 6, 8, 12, 12a-hexahydro-4-methyl-6, 8-dioxo-7-(phenylmethoxy)-, (4R, 12aS)-; RefChem:196505; (4R, 12aS)-7-(benzyloxy)-N-(2, 4-difluorobenzyl)-4-Methyl-6, 8-dioxo-3, 4, 6, 8, 12, 12a-hexahydro-2H-[1, 3]oxazino[3, 2-d]pyrido[1, 2-a]pyrazine-9-carboxaMide; MFCD22741602; (4R, 12aS)-N-(2, 4-difluorobenzyl)-7-benzylhydroxy-4-Methyl-6, 8-dioxo-3, 4, 6, 8, 12, 12a-hexahydro-2H-pyrido[1', 2'; (3S, 7R)-N-[(2, 4-Difluorophenyl)methyl]-7-methyl-9, 12-dioxo-11-phenylmethoxy-4-oxa-1, 8-diazatricyclo[8.4.0.03, 8]tetradeca-10, 13-diene-13-carboxamide; Dolutegravir Impurity 22; Dolutegravir Impurity 78; UNII-SJ4GZ8739L; (4R, 12aS)-N-[(2, 4-Difluorophenyl)methyl]-3, 4, 6, 8, 12, 12a-hexahydro-4-methyl-6 and 8-dioxo-7-(phenylmethox; SCHEMBL2302444; C27H25F2N3O5; AKOS027323537
(3S, 7R)-N-[(2, 4-difluorophenyl)methyl]-7-methyl-9, 12-dioxo-11-phenylmethoxy-4-oxa-1, 8-diazatricyclo[8.4.0.03, 8]tetradeca-10 and 13-diene-13-carboxamide
InChI=1S/C27H25F2N3O5/c1-16-9-10-36-22-14-31-13-20(26(34)30-12-18-7-8-19(28)11-21(18)29)24(33)25(23(31)27(35)32(16)22)37-15-17-5-3-2-4-6-17/h2-8,11,13,16,22H,9-10,12,14-15H2,1H3,(H,30,34)/t16-,22+/m1/s1